로딩 중…
지수 로딩 중…
인바이오
352940· KOSDAQ· Materials· Materials
₩2,100-1.18%
2026-09-18
Financials
Valuation Metrics
인바이오's Market Cap is ₩228B. At end of 2025 it was ₩247B. Ranked #2263 of 2,421 in KR market (top 93%), #1497 of 1,640 on KOSDAQ (top 91%), #273 of 294 in Materials (top 93%) by Market Cap.
Investment Metrics(as of 2026-09-18)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | 22.82B KRW | KR#2,263/2,421 Sec#273/294 |
| Revenue | 36.18B KRW | KR#1,961/2,421 Sec#269/294 |
| Net Income | 574.5M KRW | KR#1,514/2,421 Sec#200/294 |
| Total Assets | 78.88B KRW | KR#1,943/2,421 Sec#262/294 |
| Net Assets | 44.52B KRW | KR#1,984/2,421 Sec#261/294 |
| Employees | 147 | KR#1,343/2,421 Sec#166/294 |
| Value | ||
| P/E | 39.72x | KR#1,373/2,421 Sec#185/294 |
| P/B | 0.51x | KR#827/2,421 Sec#163/294 |
| PEG | 0.13x | KR#465/2,421 Sec#57/294 |
| P/S | 0.63x | KR#1,076/2,421 Sec#187/294 |
| EV/EBITDA | 35.79x | KR#1,258/2,421 Sec#167/294 |
| FCF Yield | 9.93% | KR#612/2,421 Sec#73/294 |
| Profitability | ||
| ROE | 1.29% | KR#1,462/2,421 Sec#187/294 |
| ROA | 0.73% | KR#1,441/2,421 Sec#188/294 |
| Op. Margin | 3.40% | KR#1,185/2,421 Sec#136/294 |
| Revenue Growth | 7.81% | KR#1,033/2,421 Sec#118/294 |
| Earnings Growth | 305.71% | KR#163/2,421 Sec#21/294 |
| Financial Health | ||
| Debt Ratio | 77.17% | KR#1,308/2,421 Sec#160/294 |
| Total Debt | 23.73B KRW | KR#1,326/2,421 Sec#207/294 |
| FCF | 2.27B KRW | KR#1,064/2,421 Sec#127/294 |
| Cash | 2.51B KRW | KR#2,197/2,421 Sec#269/294 |
| Current Ratio | 1.72x | KR#1,018/2,421 Sec#110/294 |
| Net Debt/EBITDA | 17.24x | KR#1,347/2,421 Sec#175/294 |
| Performance | ||
| 1Y Return | -7.49% | KR#901/2,421 Sec#117/294 |
| 1M Return | 3.70% | KR#867/2,421 Sec#101/294 |
| From 52W High | -13.58% | KR#129/2,421 Sec#25/294 |
| 1Y MDD | -17.84% | KR#41/2,421 Sec#14/294 |
| Trading | ||
| Volume | 13,243 shares | KR#1,792/2,421 Sec#192/294 |
| Trading Value | 27.5M KRW | KR#2,058/2,421 Sec#236/294 |
| Foreign Own. | 1.26% | KR#1,932/2,421 Sec#230/294 |
| Per Share | ||
| EPS | 53 KRW | KR#1,495/2,421 Sec#195/294 |
| BPS | 4,097 KRW | KR#1,645/2,421 Sec#226/294 |
Company Info
동사는 1997년 농약 제조 및 판매를 목적으로 설립된 후 2020년 코스닥시장에서 상장됨. 살균, 살충, 제초제 등 작물 보호제와 비료를 농협경제지주 및 지역별 도소매상을 통해 판매하고, 다기능 살균살충제 및 친환경 작물보호제를 생산함. 최근 10년간 174품목 개발 등록과 노동력 절감 효과가 있는 합제 및 고부가가치 제품 개발에 집중하며, 세계 최초 바이러스 치료제 등록 신청 등 지속적인 연구개발을 추진하고 있음. 인바이오는 1997년에 설립되었으며 경기도 군포시에 본사를 두고 있습니다.